A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications.
Read the story here.
WIRED Science
2,104 clip(s)
Everyone Was Wrong About Antipsychotics
Covid’s Summer Wave Is Rising—Again
This Prosthetic Limb Actually Attaches to the Wearer’s Nerves